Who owns Avita Therapeutics Inc?
- Ticker: RCEL
- CUSIP Number: 05380c102
Tip: Access positions for across all investors
Analyze quarterly positions in Avita Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avita Therapeutics stock
Who bought or sold Avita Therapeutics Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 1.7M | $28M | 2% | Mar 2024 |
|
| Vanguard Group | 1.4M | $23M | 1% | Mar 2024 |
|
| Geode Capital Management | 543k | $8.7M | 9% | Mar 2024 |
|
| AWM Investment Company | 497k | $8.0M | 0% | Mar 2024 |
|
| Silvercrest Asset Management Group | 242k | $3.9M | 100% | Mar 2024 |
|
| Northern Trust | 218k | $3.5M | 0% | Mar 2024 |
|
| CenterBook Partners | 145k | $2.3M | 100% | Mar 2024 |
|
| Bank of New York Mellon | 108k | $1.7M | -8% | Mar 2024 |
|
| AQR Capital Management | 91k | $1.4M | 46% | Mar 2024 |
|
| Goldman Sachs Group | 81k | $1.3M | 191% | Mar 2024 |
|
| Soleus Capital Management | 75k | $1.2M | 0% | Mar 2024 |
|
| 1492 Capital Management | 72k | $1.2M | 0% | Mar 2024 |
|
| Nuveen Asset Management | 72k | $1.1M | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 67k | $1.1M | -3% | Mar 2024 |
|
| Citadel Advisors | 53k | $849k | 106% | Mar 2024 |
|
| Ameriprise Financial | 52k | $831k | -55% | Mar 2024 |
|
| Rafferty Asset Management | 52k | $827k | 100% | Mar 2024 |
|
| UBS Group | 52k | $826k | 157% | Mar 2024 |
|
| D. E. Shaw & Co | 48k | $772k | -5% | Mar 2024 |
|
| Citigroup | 47k | $752k | 1221% | Mar 2024 |
|
| Dimensional Fund Advisors | 46k | $730k | -52% | Mar 2024 |
|
| Hussman Econometrics Advisors | 42k | $673k | 100% | Mar 2024 |
|
| Morgan Stanley | 40k | $638k | -75% | Mar 2024 |
|
| Pura Vida Investments | 35k | $561k | -93% | Mar 2024 |
|
| Rhumbline Advisers | 32k | $514k | 3% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 32k | $506k | -23% | Mar 2024 |
|
| Bank of America Corporation | 30k | $486k | -21% | Mar 2024 |
|
| Wellington Management Company | 28k | $383k | 100% | Dec 2023 |
|
| Susquehanna International | 21k | $331k | -72% | Mar 2024 |
|
| Clearline Capital | 21k | $331k | 0% | Mar 2024 |
|
| Barclays | 20k | $325k | -41% | Mar 2024 |
|
| Aigen Investment Management | 16k | $220k | 100% | Dec 2023 |
|
| Financial Advisory | 16k | $249k | -14% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 15k | $245k | -5% | Mar 2024 |
|
| T. Rowe Price Associates | 15k | $232k | 8% | Mar 2024 |
|
| MetLife Investment Advisors | 14k | $187k | 0% | Dec 2023 |
|
| RMB Capital Management | 13k | $178k | 100% | Dec 2023 |
|
| Jane Street | 13k | $208k | -47% | Mar 2024 |
|
| American International | 13k | $171k | 0% | Dec 2023 |
|
| Two Sigma Advisers | 12k | $192k | -69% | Mar 2024 |
|
| Franklin Resources | 12k | $189k | 100% | Mar 2024 |
|
| Semanteon Capital Management | 11k | $178k | 100% | Mar 2024 |
|
| Quest Partners | 11k | $169k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 10k | $165k | -38% | Mar 2024 |
|
| Wells Fargo & Company | 9.5k | $153k | 12% | Mar 2024 |
|
| New York State Common Retirement Fund | 9.4k | $151k | 17% | Mar 2024 |
|
| Lazard Asset Management | 5.8k | $79k | 8% | Dec 2023 |
|
| TD Waterhouse Canada | 5.0k | $76k | 500000% | Mar 2024 |
|
| Advisor Group Holdings | 3.4k | $54k | 4% | Mar 2024 |
|
| Legal & General Group | 2.7k | $44k | -3% | Mar 2024 |
|
| California State Teachers Retirement System | 2.5k | $41k | -54% | Mar 2024 |
|
| Summit Investment Advisors | 2.1k | $33k | 0% | Mar 2024 |
|
| HighMark Wealth Management | 2.0k | $32k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.5k | $25k | -78% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.4k | $19k | 0% | Dec 2023 |
|
| Amalgamated Bank | 848.00 | $14k | -76% | Mar 2024 |
|
| FMR | 726.00 | $12k | -18% | Mar 2024 |
|
| Capital Analysts | 652.00 | $10k | 0% | Mar 2024 |
|
| Cutler | 550.00 | $8.6k | 0% | Mar 2024 |
|
| Russell Investments | 506.00 | $8.1k | 130% | Mar 2024 |
|
| ICA Group Wealth Management | 500.00 | $8.0k | 0% | Mar 2024 |
|
| Simplex Trading | 397.00 | $6.0k | -85% | Mar 2024 |
|
| Orion Capital Management | 300.00 | $4.8k | 0% | Mar 2024 |
|
| CWM | 259.00 | $4.0k | 30% | Mar 2024 |
|
| Tower Research Capital | 248.00 | $4.0k | -55% | Mar 2024 |
|
| Pacer Advisors | 244.00 | $3.9k | 100% | Mar 2024 |
|
| Cape Investment Advisory | 213.00 | $2.9k | 100% | Dec 2023 |
|
| Northwestern Mutual Wealth Management Company | 100.00 | $1.6k | 100% | Mar 2024 |
|
| GAMMA Investing | 79.00 | $1.3k | 365% | Mar 2024 |
|
| Steward Partners Investment Advisory | 52.00 | $834.002000 | 0% | Mar 2024 |
|
| Allspring Global Investments Holdings | 49.00 | $784.999600 | -46% | Mar 2024 |
|
| NISA Investment Advisors | 46.00 | $736.998200 | 229% | Mar 2024 |
|
| Parallel Advisors | 40.00 | $641.000000 | 0% | Mar 2024 |
|
| Ronald Blue Trust | 20.00 | $321.000000 | 100% | Mar 2024 |
|
| Global Wealth Strategies & Associates | 20.00 | $274.000000 | 0% | Dec 2023 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 5.00 | $80.000000 | 100% | Mar 2024 |
|
Who sold out of Avita Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Eudaimonia Asset Management | Sep 2023 | 249k | $3.6M |
| Bridgeway Capital Management | Sep 2023 | 29k | $417k |
| Sei Investments | Sep 2023 | 21k | $308k |
| Jump Financial | Sep 2023 | 16k | $234k |
| Mirae Asset Global Investments | Dec 2023 | 12k | $170k |
| Winton Capital | Dec 2023 | 12k | $158k |
| Two Sigma Investments | Dec 2023 | 11k | $152k |
| Ing Investment Management | Sep 2023 | 10k | $152k |
| Cubist Systematic Strategies | Dec 2023 | 10k | $138k |
| Dorsey Wright & Associates | Sep 2023 | 1.4k | $21k |
| White Bay PT | Sep 2023 | 1.0k | $15k |
| Point72 Middle East FZE | Dec 2023 | 803.00 | $11k |
| Federated Investors | Sep 2023 | 697.00 | $10k |
| Global Retirement Partners | Dec 2023 | 642.00 | $9.2k |
| BFSG | Dec 2023 | 300.00 | $4.1k |